Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-10

Clinical Trial Update: Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone)

View source ↗

Summary

Completed the Special Drug Use Investigation for Advair Diskus (salmeterol and fluticasone) in chronic obstructive pulmonary disease. The study was sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADVAIR DISKUS (fluticasone propionate and salmeterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED